SO
RGNX icon

STRS Ohio’s Regenxbio RGNX Stock Holding History

STRS Ohio’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,900
Closed -$678K – 2040
2022
Q4 		$678K Hold
29,900
– – ﹤0.01% 1127
2022
Q3 		$790K Sell
29,900
-1,500
-5% -$44.5K ﹤0.01% 1040
2022
Q2 		$775K Buy
31,400
+13,900
+79% +$347K ﹤0.01% 1065
2022
Q1 		$580K Buy
17,500
+11,200
+178% +$311K ﹤0.01% 1383
2021
Q4 		$206K Hold
6,300
– – ﹤0.01% 1732
2021
Q3 		$264K Buy
6,300
+900
+17% +$32.4K ﹤0.01% 1698
2021
Q2 		$209K Buy
+5,400
New +$193K ﹤0.01% 1807
2019
Q3 		– Sell
-18,000
Closed -$924K – 2143
2019
Q2 		$924K Hold
18,000
– – ﹤0.01% 866
2019
Q1 		$1.03M Sell
18,000
-1,400
-7% -$69.4K ﹤0.01% 812
2018
Q4 		$813K Buy
19,400
+2,800
+17% +$164K ﹤0.01% 877
2018
Q3 		$1.25M Sell
16,600
-2,200
-12% -$159K 0.01% 782
2018
Q2 		$1.35M Buy
18,800
+4,600
+32% +$220K 0.01% 769
2018
Q1 		$423K Sell
14,200
-8,400
-37% -$244K ﹤0.01% 1365
2017
Q4 		$751K Sell
22,600
-600
-3% -$18.1K ﹤0.01% 1054
2017
Q3 		$764K Sell
23,200
-11,800
-34% -$266K ﹤0.01% 1065
2017
Q2 		$691K Buy
35,000
+2,100
+6% +$40.7K ﹤0.01% 1109
2017
Q1 		$634K Buy
32,900
+15,900
+94% +$307K ﹤0.01% 1210
2016
Q4 		$315K Hold
17,000
– – ﹤0.01% 1469
2016
Q3 		$238K Sell
17,000
-12,600
-43% -$139K ﹤0.01% 1514
2016
Q2 		$236K Buy
29,600
+4,859
+20% +$53.9K ﹤0.01% 1514
2016
Q1 		$267K Buy
24,741
+22,341
+931% +$286K ﹤0.01% 1447
2015
Q4 		$39K Buy
+2,400
New +$47.6K ﹤0.01% 1811

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

STRS Ohio's RGNX Position: Q1 2023 in Review

STRS Ohio sold out of Regenxbio (RGNX) in Q1 2023, closing a stake of 29,900 shares — an estimated $678K sold.

STRS Ohio first reported a position in RGNX in Q4 2015 and held it in 22 quarters. The position peaked at $1.35M in Q2 2018. 174 funds tracked by Wall St. Rank hold RGNX as of Q1 2023.

  • STRS Ohio reported no remaining Regenxbio position as of Q1 2023 after selling out during the quarter.
  • STRS Ohio sold 29,900 Regenxbio shares in Q1 2023, an estimated $678K.
  • STRS Ohio first reported a position in Regenxbio in Q4 2015 and held it in 22 quarters.
  • STRS Ohio's Regenxbio position peaked at $1.35M in Q2 2018.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q1 2023.

Based on STRS Ohio's 13F filing for Q1 2023, filed 27 Apr 2023.